Skip to content

Application of low opioid general anesthesia in elderly patients undergoing hip surgery

Application of low opioid general anesthesia in elderly patients undergoing hip surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094791
Enrollment
Unknown
Registered
2024-12-27
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Low-dose opioid total intravenous anesthesia group.:Reducing the dose of opioids during anesthesia induction and postoperative analgesia
Conventional dose opioid total intravenous anesthesia group.:Using conventional doses of opioid medications during anesthesia induction and postoperative analgesia.

Sponsors

Shaanxi 215 Hospital of nuclear industry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
80 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Scheduled for hip fracture surgery, no contraindications to surgery. 2.American Society of Anesthesiologists (ASA) physical status classification ranges from II to III. 3.Patient age >= 80 years, with an expected survival of = 6 months;

Exclusion criteria

Exclusion criteria: 1.Dementia or severe hearing impairment resulting in an inability to communicate; 2.Preoperative delirium or currently using psychotropic medication; 3.Allergic history related to medication, history of drug dependency; 4.Refusal to use postoperative analgesic pump for pain relief; 5.Patients who refused to participate in the study;

Design outcomes

Primary

MeasureTime frame
Postoperative Recovery Status at 24 and 48 Hours (QoR-15 Scale);Burst suppression;

Secondary

MeasureTime frame
Suppression of intubation response;Stress level;Postoperative pain;Compare the amount of opioids used during the perioperative period between the two groups.;

Countries

China

Contacts

Public ContactWeilong Liang

Shaanxi 215 Hospital of nuclear industry

liangweilong209@163.com+86 29 3208 8351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026